CUSIP 00887A204COM NEWRNTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
48 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Voss Capital, LP | 4.24M | $4.92M | +1.58M | Added |
| 2 | Bios Capital Management, LP | 1.69M | $1.96M | 0 | Held |
| 3 | Vanguard Group Inc | 1.17M | $1.35M | −2.6K | Reduced |
| 4 | University Of Texas/Texas Am Investment Management Co | 511.6K | $593.5K |
| 0 |
| Held |
| 5 | Prosight Management, LP | 442.6K | $513.4K | −125.3K | Reduced |
| 6 | Cable Car Capital, LP | 420.0K | $487.2K | 0 | Held |
| 7 | Geode Capital Management, LLC | 284.6K | $330.2K | +37.2K | Added |
| 8 | Texas Capital Bank Wealth Management Services Inc | 262.1K | $304.1K | +236.0K | Added |
| 9 | Sigma Planning Corp | 247.3K | $298.6K | −6.5K | Reduced |
| 10 | Gagnon Securities LLC | 240.2K | $278.7K | +11.5K | Added |
See every fund holding Rein Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders